Eton Pharmaceuticals Inc.

NASDAQ: ETON · Real-Time Price · USD
17.01
0.31 (1.86%)
At close: Aug 15, 2025, 3:59 PM
17.04
0.18%
After-hours: Aug 15, 2025, 04:10 PM EDT

Eton Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
18.93M 17.28M 11.65M 10.32M 9.07M 7.97M 7.31M 7.03M 12M 5.3M 8.5M 3.22M 7.36M 2.18M 6.09M 775K 3.07M 11.9M
Cost of Revenue
7M 7.42M 5.17M 4.02M 3.45M 2.96M 3.68M 2.63M 2.31M 1.96M 2.14M 1.2M 2.75M 718K 280K 617K 136K 1.59M
Gross Profit
11.92M 9.86M 6.48M 6.3M 5.63M 5.01M 3.63M 4.4M 9.68M 3.35M 6.36M 2.02M 4.61M 1.46M 5.81M 158K 2.93M 10.31M
Operating Income
-1.48M -470K 629K 509K -2.94M -800K -1.99M -548K 3.88M -2.53M 810K -2.9M -1.34M -5.09M 1.31M -5.85M -2.33M 5.36M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 150K n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-2.52M -1.5M -511K 501K -2.99M -811K -2.01M -579K 4.56M -2.66M 912K -3.04M -1.56M -5.33M 1.04M -6.09M -2.02M 5.12M
Net Income
-2.58M -1.57M -598K 627K -3.04M -811K -2.26M -579K 4.56M -2.91M 912K -3.19M -1.56M -5.57M 1.04M -6.09M -2.02M 5.12M
Selling & General & Admin
9.69M 9.17M 6.72M 5.29M 5.59M 5.16M 4.58M 4.34M 4.67M 5.34M 4.35M 4.17M 5.26M 4.93M 3.82M 3.33M 3.27M 4.06M
Research & Development
3.71M 1.16M -871K 505K 2.97M 651K 1.05M 615K 1.13M 535K 944K 744K 690K 1.62M 681K 2.68M 1.99M 886K
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
13.4M 10.33M 5.85M 5.79M 8.56M 5.81M 5.62M 4.95M 5.8M 5.88M 5.3M 4.91M 5.95M 6.54M 4.5M 6M 5.26M 4.94M
Interest Expense
1.2M 1.16M 1.33M 8K 52K 11K 222K 31K 124K 126K 256K 150K 218K 243K 275K 247K 237K 247K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a -1K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
20.4M 17.75M 11.02M 9.81M 12.01M 8.77M 9.3M 7.58M 8.11M 7.84M 7.44M 6.11M 8.7M 7.26M 4.78M 6.62M 5.39M 6.53M
Income Tax Expense
66K 74K 87K -126K 54K n/a 247K n/a n/a 252K -102K 150K n/a 243K n/a 4K n/a n/a
Shares Outstanding (Basic)
26.89M 26.89M 26.14M 25.9M 25.78M 25.76M 25.74M 25.72M 25.59M 25.52M 25.38M 25.36M 25.13M 25.3M 25.29M 25.28M 25.2M 24.45M
Shares Outstanding (Diluted)
26.89M 26.89M 26.14M 26.55M 25.78M 25.76M 25.74M 25.72M 25.98M 25.52M 25.69M 25.36M 25.13M 25.3M 25.96M 25.28M 25.21M 26.55M
EPS (Basic)
-0.1 -0.06 -0.02 0.02 -0.12 -0.03 -0.09 -0.02 0.18 -0.11 0.04 -0.13 -0.06 -0.22 0.04 -0.24 -0.08 0.21
EPS (Diluted)
-0.1 -0.06 -0.02 0.02 -0.12 -0.03 -0.09 -0.02 0.18 -0.11 0.04 -0.13 -0.06 -0.22 0.04 -0.24 -0.08 0.19
EBITDA
-1.48M -470K 1.18M 787K -2.66M -548K -1.37M -357K 3.88M -2.32M 1.31M -2.73M -169K -4.91M 989K -5.77M -1.69M 5.52M
EBIT
-1.32M -470K 822K 509K -2.94M -800K -1.65M -548K 3.88M -2.53M 1.06M -2.9M -1.34M -5.09M 1.31M -5.85M -1.78M 5.36M
Depreciation & Amortization
n/a 1.01M 355K 278K 279K 252K 275K 191K 211K 213K 252K 170K 1.17M 172K 134K 81K 85K 155K